The launch of an oral semaglutide pill approved for weight loss represents a new frontier for GLP-1 drugs. Katie Rosseinsky ...

The U.S. Food and Drug Administration approved the Wegovy pill in late December 2025 for adults who are obese or overweight ...

Novo Nordisk's FDA-approved Wegovy pill marks a new era in obesity treatment, expanding access to GLP-1 therapy through ...

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection.

The Wegovy pill comes in tablet form—and is the first U.S. Food & Drug Administration (FDA)-approved GLP-1 to do so. Its ...

The weight loss drug Wegovy is now available as a tablet in more than 70,000 U.S. pharmacies as well as select telehealth ...

In coming weeks, Wegovy pill will be available in four doses: a starter dose of 1.5 mg, as well as 4 mg, 9 mg, and 25 mg. As ...

MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from ...

Novo Nordisk’s new Wegovy pill hit the market this week. The Danish drug maker, best known for GLP-1 injections like Ozempic ...

This big bottle cuts the fat from your bathroom and countertops, letting you dump seven different capsules into a sealed-off ...

Clinical trials have shown that the pill can deliver comparable weight-loss results to the injectable form when used ...